`
`Page 1 of 2
`
`EQA___tig_n1e3 D_tug___l2.aial2a§e§4 .l2tugseEElA5
`
`'
`
`.
`
`' iroes@m
`
`
`FDA Approved Drug Products
`
`Back} watery;
`
`Drug Details
`
`Drug Name{5)
`FDA Appiication No.
`Active ingredienfls)
`Company
`Original Approval or Tentative Approval Date
`Chemical Type
`Review Classification
`
`FAQ6 i
`
`Instructions'7 i Glossary8 l
`
`Contact Us9
`
`'Email Link
`
`RESTASIS
`(NDA) 050793
`CYCLOSPORINE
`ALLERGAN
`December 23, 2002
`3 New dosage form
`i3 Priority review drug
`
`a There are no Therapeutic Equivaients
`
`- Label Information
`
`a Approval History, Letters, Reviews, and
`Related Documents
`
`Products on Application (NDA) #050790
`Click on a column header to re-sort the table:
`
`Drug Name
`
`Active Ingredients
`
`Strength
`
`Dosage Form/Route
`
`RESTASIS
`
`CYCLOSPORINE
`
`0.05%
`
`EMULSION;OPHTHALMIC
`
`Marketing
`Status
`Prescription
`
`RLD TE
`Code
`Yes None
`
`Back to Top 5 Back to Previous Page | Back to Drugs@FDA Home
`
`Disclaimer10
`
`FDA/Center for Drug Evaluation and Research
`Office of Communications
`Division of Online Communications
`
`Update Frequency: Daily
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?uSO8=true&v:152&usernamemfdamain
`N
`
`http ://www.addthis.com/bookmark. php
`
`http://www.fda.gov/default.htm
`
`http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`http://www.accessdata .fda.gov/scripts/cder/d rugsatfcia/index.cfm
`
`http://www.fda.gov/Drugs/InformationOnDrugs/ucm075234htm
`
`http ://www.fda .gov/Drugs/InformationOnDrugs/UCMO79874
`
`http ://www.ida .gov/Drugs/InformationOnDrLigs/ucm079436.htm
`
`http://www.accessdata.fda.gov/scripts/email/Cder/commentd rugcatcim
`
`http ://www.fda .gov/AboutFDA/AboutThisWebsite/WebsitePoiides/default. htm#web
`
`earnestness
`
`H .0
`
`Note: if you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`US. Food and Drug Administration
`
`http://WWW.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=SearchDrug..
`
`.
`
`4/14/2015
`
`APOTEX
`
`1067,pg.1
`
`APOTEX 1067, pg. 1
`
`
`
`Drugs@FDA: FDA Approved Drug Products
`
`Page 2 of 2
`
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph.
`;i.—888«INFO~FDA (1-888—463—6332)
`Email FDA
`
`this»? ,
`For Government For Press
`
`Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency
`Preparedness International Programs News & Events Training and Continuing Education Inspections/Compliance State
`8L Local Officials Consumers Industry Health Professionals FDA Archive
`{(5 List Experiment of Health Ex Human Servtms
`
`Links on this page:
`
`http://Www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=SearchDrug...
`
`4/14/2015
`
`APOTEX 1067, pg. 2
`
`APOTEX 1067, pg. 2
`
`